Denise M. Trauth Endowed Presidential Research Professorship Grant (09/01/21 – 08/31/2024) Role: PI
GM134910 NIH/NIGMS (01/01/20 – 12/31/2024) Role: co-PI
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies
GM131717 NIH/NIGMS (09/01/19 – 08/31/2021) Role: PI
Tandem Discovery of Drug Leads and Targets via Paal-Knorr Reaction
CA227680 NIH/NCI (02/01/19 – 01/31/2023) Role: PI
Acid-Sensitive Glioblastoma Prodrugs Derived from Ophiobolin A
CA186046 NIH/NCI (07/15/14 – 06/30/17) Role: PI
Mode of Action of the Amaryllidaceae Alkaloid Lycorine – Promising Anticancer Agent
CA213199 NIH/NCI (08/01/17 – 07/31/20) Role: co-PI
Discovery of New Differentiation Agents for Neuroblastoma Therapy
RR016480 NIH/NIGMS (05/01/09 – 02/28/14) Role: co-PI
Chemical Biology and Screening Collaborative Core
CA135579 NIH/NCI (03/01/09 – 02/29/12) Role: PI
Heterocyclic Analogues of Podophyllotoxin Accessible by a One-Step Multicomponent Synthesis
RR016480 NIH/NCRR (01/07/04 – 06/30/09) Role: PI
Elucidation of the Pancratistatin Cytotoxic Pharmacophore
MH074425 NIH/NIMH and NHGRI (11/30/05 – 05/31/09) Role: co-PI
New Mexico Molecular Libraries Screening Center
CA099957-02 NIH/NCI (06/01/05 – 05/31/08) Role: PI
Practical Enantiodivergent Synthesis of (+) and (-)-Pancratistatin from D-Xylose
CA099957-01 NIH/NCI (06/01/03 – 05/31/05) Role: PI
Practical Enantiodivergent Synthesis of (+) and (-)-Pancratistatin from D-Xylose
Sandia National Laboratories (10/01/03 – 09/30/04) Role: PI
Sandia-University Research Program; Direct Route to Propylene Oxide: Confronting an Industrial “Holy Grail” with a Versatile Platinum Catalyst